Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

NCT00488046 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

NIH

Sponsor class

Conditions

Influenza
Virus Diseases

Interventions

BIOLOGICAL: H5N1 (6-2) AA ca Recombinant (A/Hong Kong/213/2003 x A/AnnArbor/6/60 ca)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]